AMERISAFE (NASDAQ:AMSF – Get Free Report) is expected to release its Q3 2025 results after the market closes on Wednesday, October 29th. Analysts expect AMERISAFE to post earnings of $0.55 per share and revenue of $78.2860 million for the quarter. Interested persons can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Thursday, October 30, 2025 at 10:30 AM ET.
AMERISAFE (NASDAQ:AMSF – Get Free Report) last released its earnings results on Thursday, July 24th. The insurance provider reported $0.53 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.02). AMERISAFE had a return on equity of 16.54% and a net margin of 16.46%.The business had revenue of $79.70 million for the quarter, compared to the consensus estimate of $77.30 million. On average, analysts expect AMERISAFE to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
AMERISAFE Stock Performance
Shares of AMSF opened at $41.45 on Monday. The stock has a market capitalization of $787.14 million, a price-to-earnings ratio of 15.70 and a beta of 0.32. AMERISAFE has a 52 week low of $40.03 and a 52 week high of $60.24. The stock has a fifty day moving average of $43.90 and a 200-day moving average of $45.24.
Analyst Ratings Changes
Get Our Latest Stock Report on AMERISAFE
Insiders Place Their Bets
In other AMERISAFE news, CFO Anastasios Omiridis sold 1,343 shares of the stock in a transaction that occurred on Tuesday, August 5th. The shares were sold at an average price of $44.75, for a total value of $60,099.25. Following the transaction, the chief financial officer directly owned 2,253 shares in the company, valued at approximately $100,821.75. This trade represents a 37.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.61% of the company’s stock.
Institutional Trading of AMERISAFE
Several institutional investors and hedge funds have recently modified their holdings of AMSF. Qube Research & Technologies Ltd bought a new stake in AMERISAFE in the 2nd quarter valued at $4,345,000. Goldman Sachs Group Inc. increased its holdings in AMERISAFE by 82.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 217,280 shares of the insurance provider’s stock valued at $11,418,000 after acquiring an additional 98,293 shares during the last quarter. Marshall Wace LLP bought a new stake in AMERISAFE in the 2nd quarter valued at $3,513,000. Bank of America Corp DE increased its holdings in AMERISAFE by 12.8% in the 2nd quarter. Bank of America Corp DE now owns 607,917 shares of the insurance provider’s stock valued at $26,584,000 after acquiring an additional 68,987 shares during the last quarter. Finally, Jane Street Group LLC increased its holdings in AMERISAFE by 137.8% in the 2nd quarter. Jane Street Group LLC now owns 69,384 shares of the insurance provider’s stock valued at $3,034,000 after acquiring an additional 40,208 shares during the last quarter. 97.41% of the stock is currently owned by institutional investors.
AMERISAFE Company Profile
AMERISAFE, Inc, an insurance holding company, underwrites workers’ compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Further Reading
- Five stocks we like better than AMERISAFE
- How to trade penny stocks: A step-by-step guide
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- Overbought Stocks Explained: Should You Trade Them?
- Is Landstar the Next Big Winner in Transportation Stocks?
Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.
